Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...

Shares of Quest Diagnostics Inc. DGX slid 3.78% to $164.18 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 5.97% to 5,074.08 ...

In March, we welcomed 30 new analysts to Seeking Alpha, and in this article we are showcasing their stock picks and ...

Quest Diagnostics Inc. closed 4.61% short of its 52-week high of $178.87, which the company reached on March 10th.

Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling.

Quest Diagnostics Incorporated's ( NYSE:DGX ) dividend will be increasing from last year's payment of the same ...

The stock is down 36.6% since reporting and currently trades at $9.16. Is now the time to buy NeoGenomics? Access our full ...

Readers hoping to buy Quest Diagnostics Incorporated (NYSE:DGX) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one business ...

Thrivent Financial for Lutherans decreased its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 7.1% ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

In addition to the positive operational results, Lucid (NASDAQ:LCID) Diagnostics anticipates a crucial development ... about Lucid Diagnostics’ future prospects and performance. The stock has shown ...

NVIDIA CORP (NVDA) is a large-cap growth stock in the Computer Hardware industry. The rating using this strategy is 100% based on the firm’s underlying fundamentals and the stock’s valuation.